Hyundai Pharm (004310) — Free Cash Flow Generation Index

Latest as of February 2026: -12.77x

Hyundai Pharm (004310) has a Free Cash Flow Generation Index of -12.77x as of February 2026. Free cash flow of ₩-2.40 Billion represents -13% of operating cash flow (₩188.28 Million). See 004310 current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

-12.77x
Free Cash Flow / Operating CF

Free Cash Flow

₩-2.40 Billion
KRW

Operating Cash Flow

₩188.28 Million
KRW

Capital Expenditures

₩2.59 Billion
KRW

Hyundai Pharm Free Cash Flow Generation Index (2010–2022)

Historical FCF Generation Index trend for Hyundai Pharm across 8 annual periods. Explore Hyundai Pharm cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for Hyundai Pharm (2010–2022)

Year-by-year Free Cash Flow Generation Index for Hyundai Pharm. For the full company profile including market capitalisation, see Hyundai Pharm market cap and net worth.

Year FCG Index Free Cash Flow (KRW) Operating CF Capital Expenditures YoY Change
2022 0.43x ₩5.04 Billion ₩11.62 Billion ₩6.58 Billion ▲ +232.7%
2021 -0.33x ₩-1.68 Billion ₩5.13 Billion ₩6.81 Billion ▼ -180.2%
2020 0.41x ₩4.40 Billion ₩10.80 Billion ₩6.40 Billion ▼ -15.4%
2019 0.48x ₩3.35 Billion ₩6.96 Billion ₩2.36 Billion ▲ +712.5%
2018 0.06x ₩168.09 Million ₩2.83 Billion ₩2.67 Billion ▼ -95.4%
2013 1.28x ₩10.19 Billion ₩7.95 Billion ₩2.24 Billion ▼ -19.3%
2011 1.59x ₩9.95 Billion ₩6.27 Billion ₩3.68 Billion ▼ -35.8%
2010 2.47x ₩6.62 Billion ₩2.68 Billion ₩3.95 Billion
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).